Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £18.86m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Director/PDMR Shareholding

31 Dec 2009 09:25

RNS Number : 8808E
Phytopharm PLC
31 December 2009
Ā 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anĀ issuerĀ to make aĀ RISĀ notification required byĀ DRĀ 3.1.4R(1).

Ā 

(1)

AnĀ issuerĀ making a notification in respect of a transaction relating to theĀ sharesĀ or debentures of theĀ issuerĀ should complete boxes 1 to 16, 23 and 24.

(2)

AnĀ issuerĀ making a notification in respect of a derivative relatingĀ toĀ theĀ sharesĀ of theĀ issuerĀ should complete boxes 1 to 4, 6, 8,Ā 13, 14, 16, 23 and 24.Ā 

(3)

AnĀ issuerĀ making a notification in respect of options granted to aĀ director/person discharging managerial responsibilitiesĀ should complete boxes 1 to 3 and 17 to 24.Ā 

(4)

AnĀ issuerĀ making a notification in respect of aĀ financial instrumentĀ relating to theĀ sharesĀ of theĀ issuerĀ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Ā 

Ā 

Please complete all relevant boxes in block capital letters.

1.Ā Name of theĀ issuer

PHYTOPHARM PLC

2.Ā State whether the notification relates to (i) a transaction notified in accordance withĀ DRĀ 3.1.4R(1)(a); orĀ (ii)Ā DRĀ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii)

(III) BOTHĀ (I)Ā AND (II)

3.Ā Name ofĀ person discharging managerial responsibilities/director

MRĀ KEITH THOMSON, INTERIM CHIEF OPERATING OFFICER

4.Ā State whether notification relates to aĀ personĀ connected with aĀ person discharging managerial responsibilities/directorĀ named in 3 and identify theĀ connected person

AS 3 ABOVE

5.Ā Indicate whether the notification is in respect of a holding of theĀ personĀ referred to in 3 or 4 above or in respect of a non-beneficial interest

AS 3 ABOVE

6.Ā Description ofĀ sharesĀ (includingĀ class), debentures or derivatives or financial instruments relating toĀ shares

ORDINARY SHARES OF 1 PENCE EACH

7.Ā Name of registered shareholders(s) and, if more than one, the number ofĀ sharesĀ held by each of them

AS 3 ABOVE

8Ā State the nature of the transaction

SHARES ACQUIRED

9.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ acquired

89,000

10.Ā Percentage of issuedĀ classĀ acquired (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)

0.03%

11.Ā Number ofĀ shares, debentures or financial instruments relating toĀ sharesĀ disposed

12.Ā Percentage of issuedĀ classĀ disposed (treasury sharesĀ of thatĀ classĀ should not be taken into account when calculating percentage)Ā 

13.Ā Price perĀ shareĀ or value of transaction

10Ā PENCE PER SHARE

14.Ā Date and place of transaction

29Ā DecemberĀ 2009, LONDON

15.Ā Total holding following notification and total percentage holding following notification (anyĀ treasury sharesĀ should not be taken into account when calculating percentage)

155,750 - 0.04%

16.Ā Date issuer informed of transaction

30 DECEMBER2009

If aĀ person discharging managerial responsibilitiesĀ has been granted options by theĀ issuerĀ complete the following boxes

17Ā Date of grant

18.Ā Period during which or date on which it can be exercised

19.Ā Total amount paid (if any) for grant of the option

20.Ā Description ofĀ sharesĀ or debentures involved (classĀ and number)

21.Ā Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.Ā Total number ofĀ sharesĀ or debentures over which options held following notification

23.Ā Any additional information

24.Ā Name of contact and telephone number for queries

ZOE MCGOWAN 01480 437697

Name and signature of duly authorised officer ofĀ issuerĀ responsible for making notification

ZOE MCGOWAN

Date of notification

31Ā DECEMBERĀ 2009

ENDĀ 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
RDSTBBLTMMTJMIL
Date   Source Headline
8th Jun 20267:00 amRNSScientific advisors & partners update
22nd May 20267:00 amRNS-RCompany presentation at Mello 2026
21st May 20267:00 amRNSContract win and contract extension
19th May 20267:00 amRNSInterim results for six months ending 31/03/2026
12th May 20267:00 amRNSIXICO Updates AI Neuroimaging Platform
28th Apr 20262:31 pmRNSHolding(s) in Company
28th Apr 20261:50 pmRNSHolding(s) in Company
28th Apr 202611:45 amRNSHolding(s) in Company
28th Apr 202610:49 amRNSHolding(s) in Company
27th Apr 20264:02 pmRNSHolding(s) in Company
27th Apr 20263:57 pmRNSHolding(s) in Company
27th Apr 20263:55 pmRNSHolding(s) in Company
27th Apr 20261:51 pmRNSHolding(s) in Company
27th Apr 202611:13 amRNSHolding(s) in Company
24th Apr 20263:30 pmRNSHolding(s) in Company
22nd Apr 202612:40 pmRNSIssue of Equity
21st Apr 20267:00 amRNSTrading Update
16th Apr 202612:01 pmRNSResult of GM and Update on Issue of Equity
7th Apr 20261:14 pmRNSResult of Retail Offer
31st Mar 20267:01 amRNSRetail Offer
31st Mar 20267:00 amRNSPlacings and Subscription
26th Mar 20267:00 amRNSCollaboration with Medidata
26th Feb 20267:00 amRNSValidation of Neuroimaging Technology Platform
12th Feb 20268:48 amRNSCorrection: c.£1.5 million Contract Extension
12th Feb 20267:00 amRNSc.£1.5 million Contract Extension
5th Feb 20267:00 amRNSAppointment of Chief Commercial Officer
23rd Jan 20265:05 pmRNSResults of AGM
9th Dec 20257:05 amRNSShare option award
9th Dec 20257:00 amRNSFinancial Results for year ended 30 September 2025
1st Dec 20257:00 amRNSOperational Update
27th Nov 20257:00 amRNSNotice of 2025 Full Year Results and IMC
17th Nov 20257:00 amRNSClinical Trial Contract Win
3rd Nov 20252:30 pmRNSCapital Markets Day Presentation and Video
16th Oct 20257:00 amRNSTrading Update
15th Oct 20257:00 amRNSNew contract win and contract extension
30th Sep 20257:00 amRNSNotice of Capital Markets Day
12th Aug 20257:00 amRNSContract Win
22nd Jul 20257:00 amRNSStrategic Data Partnership with GAP
17th Jul 20257:00 amRNSTrading Update
13th Jun 20258:03 amRNSShare option awards and PDMR Dealing
10th Jun 20257:00 amRNSFDA Clearance of Alzheimer's Diagnostic Biomarker
20th May 20256:00 pmRNSHolding(s) in Company
20th May 20257:00 amRNSHalf-year Report
8th May 202511:30 amRNSHolding(s) in Company
6th May 20257:00 amRNSNotice of Interim Results & Investor Presentation
16th Apr 20257:00 amRNSTrading Update
27th Feb 20257:00 amRNSContract Win
12th Feb 20257:00 amRNSFurther Validation of IXICO’s AI Imaging Platform
7th Feb 20253:00 pmRNSIssue of share options and PDMR dealing
24th Jan 20252:16 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.